First published · Last updated
Immunohistochemical and Molecular Biomarkers in Diffuse Large B-Cell Lymphoma: A Systematic Review of Diagnostic, Prognostic, and Therapeutic Implications
A posted systematic review evaluates protein- and genetic-level biomarkers used to diagnose, predict outcomes, and guide treatment in diffuse large B‑cell lymphoma. The item is posted content published by Springer Science and Business Media LLC on 2026-09-29.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
The review synthesizes evidence about biomarkers with potential diagnostic, prognostic, and therapeutic relevance for this lymphoma.

